Curasight

📍 Copenhagen, Denmark🗓 Founded 2013👥 9 employees💰 Last funded Jun 2021
Biotechnology Research🌐 curasight.com
Website LinkedIn
Curasight is built on more than a decade of research in PET imaging in cancer diseases at the University of Copenhagen and Rigshospitalet. Part of our company strategy is focused on the discovery and development of novel radiopharmaceuticals for improved diagnose, risk-stratification and treatment monitoring in cancer diseases using PET imaging. Our current PET ligand discovery research program and our academic collaborations are focused on discovering and developing disease-specific PET ligands for multiple cancer indications. Another part of our strategy is to develop partnerships with larger pharmaceutical or biotechnology firms that improve our ability to move new PET ligands through the late stage clinical trials and to bring them into the marketplace.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Curasight?
Curasight has 1 investors on record on gritt.io and 1 late-stage investors.
When did Curasight last raise funding?
The most recent investment in Curasight recorded on gritt.io was in June 2021.
When was Curasight founded?
Curasight was founded in 2013.
What industry is Curasight in?
Curasight operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Curasight based?
Curasight is headquartered in Copenhagen, Denmark.